Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Spero Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on Tuesday, August 12, 2025
-
Ceribell Reports Second Quarter 2025 Financial Results
-
Amwell® Announces Results for Second Quarter 2025
-
Paylocity Announces Fourth Quarter and Full Fiscal Year 2025 Financial Results
-
Tenon Medical, Inc. Announces Timing of Second Quarter 2025 Financial Results
-
ClearSign Technologies Corporation Announces Second Quarter 2025 Conference Call
-
-
Carlyle Secured Lending, Inc. Announces Financial Results For Second Quarter Ended June 30, 2025, Declares Third Quarter 2025 Dividend of $0.40 Per Common Share
-
Revolve Group Announces Second Quarter 2025 Financial Results
-
Clearway Energy, Inc. Reports Second Quarter 2025 Financial Results
-
Porch Group Reports Second Quarter 2025 Results
-
Ultragenyx Reports Second Quarter 2025 Financial Results and Corporate Update
-
First Acceptance Corporation Reports Operating Results for the Three and Six Months Ended June 30, 2025
-
Atomera Provides Second Quarter 2025 Results
-
Fractyl Health Reports Potent and Durable Two-Year Real-World Outcomes with Revita® Showing Sustained Weight Loss and Improved Glucose Control After a Single Procedure
-
Spyre Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Micromem Technologies Introduces High-Sensitivity Nanowire Gas Sensor with Tunable Amplification for Industrial Safety and Environmental Monitoring
-
Grocery Outlet Holding Corp. Announces Second Quarter Fiscal 2025 Financial Results
-
Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025
-
ScanTech AI Announces DeMeakey Williams, Sr. as Senior Vice President of Sales, Business Development, and Investor Relations
-
Latham Group, Inc. Reports Second Quarter 2025 Financial Results
-
Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne
-
HALOZYME RAISES 2025 FINANCIAL GUIDANCE RANGES AND REPORTS STRONG SECOND QUARTER 2025 RESULTS
-
AMGEN REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
-
OneSpan Reports Second Quarter 2025 Financial Results
-
Premium Global Income Split Corp. Declares Monthly Distribution
-
Advanced Energy Reports Second Quarter 2025 Results
-
Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution
-
Skyworks Reports Q3 Fiscal 2025 Results
-
Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for Its ETF Class
-
Gulfport Energy Reports Second Quarter 2025 Financial and Operating Results
-
Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update
-
Cerus Corporation Announces Second Quarter 2025 Financial Results
-
Personalis Reports Second Quarter 2025 Financial Results
-
Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution
-
Gossamer Bio Announces Second Quarter 2025 Financial Results and Provides Business Update
-
SLR Investment Corp. Announces Quarter Ended June 30, 2025 Financial Results
-
United Fire Group, Inc. reports second quarter 2025 results
-
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2025
-
BridgeBio Reports Second Quarter 2025 Financial Results and Business Updates
-
OrthoPediatrics Corp. Announces Continued Expansion of Specialty Bracing Division Into New Territories with Multiple Clinics
-
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
Premium Income Corporation Announces Monthly Distribution
-
Cirrus Logic Reports Fiscal First Quarter Revenue of $407.3 Million
-
Quest Technology Management Wins Telarus Charlie Lomond Award
-
Standard Nuclear Selected for DOE Office of Nuclear Energy Fuel Line Pilot Program
-
CVD Equipment Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025
-
Smartsheet Announces Leadership Updates
-
IMUNON Recaps Highlights from 2025 Second Quarter Financial Results Conference Call
-
Pacira BioSciences Reports Second Quarter 2025 Financial Results
